Detalhe da pesquisa
1.
Corrigendum: mTORC1-dependent AMD1 regulation sustains polyamine metabolism in prostate cancer.
Nature;
554(7693): 554, 2018 02 22.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29342137
2.
mTORC1-dependent AMD1 regulation sustains polyamine metabolism in prostate cancer.
Nature;
547(7661): 109-113, 2017 07 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28658205
3.
Methodological aspects of the molecular and histological study of prostate cancer: focus on PTEN.
Methods;
77-78: 25-30, 2015 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25697760
4.
Epigenetic Mechanisms Influencing Therapeutic Response in Breast Cancer.
Front Oncol;
12: 924808, 2022.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35774123
5.
The Oncogenic PI3K-Induced Transcriptomic Landscape Reveals Key Functions in Splicing and Gene Expression Regulation.
Cancer Res;
82(12): 2269-2280, 2022 06 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35442400
6.
PI3K-regulated Glycine N-methyltransferase is required for the development of prostate cancer.
Oncogenesis;
11(1): 10, 2022 Feb 23.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35197445
7.
FOXA1 mutations influence the therapeutic response of breast cancer by altering chromatin state.
Mol Cell Oncol;
8(3): 1891831, 2021.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34027035
8.
TRK xDFG Mutations Trigger a Sensitivity Switch from Type I to II Kinase Inhibitors.
Cancer Discov;
11(1): 126-141, 2021 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33004339
9.
Targeting PML in triple negative breast cancer elicits growth suppression and senescence.
Cell Death Differ;
27(4): 1186-1199, 2020 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31570853
10.
FOXA1 Mutations Reveal Distinct Chromatin Profiles and Influence Therapeutic Response in Breast Cancer.
Cancer Cell;
38(4): 534-550.e9, 2020 10 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32888433
11.
Genetic manipulation of LKB1 elicits lethal metastatic prostate cancer.
J Exp Med;
217(6)2020 06 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32219437
12.
PI3K Inhibition Activates SGK1 via a Feedback Loop to Promote Chromatin-Based Regulation of ER-Dependent Gene Expression.
Cell Rep;
27(1): 294-306.e5, 2019 04 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30943409
13.
Oil for the cancer engine: The cross-talk between oncogenic signaling and polyamine metabolism.
Sci Adv;
4(1): eaar2606, 2018 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29376126
14.
Low-dose statin treatment increases prostate cancer aggressiveness.
Oncotarget;
9(2): 1494-1504, 2018 Jan 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29416709
15.
PPARδ Elicits Ligand-Independent Repression of Trefoil Factor Family to Limit Prostate Cancer Growth.
Cancer Res;
78(2): 399-409, 2018 01 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29187400
16.
Erratum: The metabolic co-regulator PGC1α suppresses prostate cancer metastasis.
Nat Cell Biol;
19(7): 873, 2017 Jun 29.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28659639
17.
HEY1 functions are regulated by its phosphorylation at Ser-68.
Biosci Rep;
36(3)2016 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27129302
18.
Transcriptomic profiling of urine extracellular vesicles reveals alterations of CDH3 in prostate cancer.
Oncotarget;
7(6): 6835-46, 2016 Feb 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26771841
19.
Stratification and therapeutic potential of PML in metastatic breast cancer.
Nat Commun;
7: 12595, 2016 08 24.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27553708
20.
The metabolic co-regulator PGC1α suppresses prostate cancer metastasis.
Nat Cell Biol;
18(6): 645-656, 2016 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27214280